Mantle Therapeutics

A graphic symbolizing one group acquiring another
Biotech

Lexeo acquires Mantle for $8M, adding Friedreich ataxia assets

Lexeo has agreed to acquire Mantle Therapeutics via an upfront payment of $8.3 million while locking in three strategic collaborations.
Will Maddox Sep 22, 2026 9:58am